Claude Helps Design Scorpion Antivenom Candidates
Five investment researchers worked with Claude to test ideas for scorpion antivenom on a $200,000 budget, exploring protein binders that could stop venom toxins. The approach is early and the proteins' actual ability to stop venom remains unproven. It's a small but concrete example of AI being used outside pure drug-company R&D pipelines for biology research.
Why it matters
๐ป Developer ยท An example of using AI models as a research collaborator for protein design, worth watching if you work in computational biology tooling.
๐ฆ Product ยท Shows a pattern of non-specialist teams using general AI models to prototype scientific ideas cheaply before committing serious capital.
๐จ Design ยท No direct relevance, but illustrates AI lowering the barrier to entry for specialized scientific exploration.
๐ Business ยท A small team did exploratory antivenom research for $200K using AI, a sign of how cheap early-stage biotech experimentation is becoming.
๐ค Just Curious ยท A small team used Claude to brainstorm and test ideas for scorpion antivenom, though nobody knows yet if it actually works.
Sources: Claude helps investment researchers test scorpion antivenom ideas